Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Diversity in clinical trials
Biotech
ASH 2025 marked by ‘enduring activism’ and ‘cautious optimism’
While references to the Trump administration's attacks on science were prominent, an optimistic ASH was all about the data—and puppies.
Darren Incorvaia
Dec 9, 2025 3:15pm
BMS boosts cancer trials with Sarah Cannon's platform
Nov 12, 2025 12:30pm
CRO Veeda picks Mango for generative AI platform
Jul 9, 2025 7:23am
Headlands Research’s network expands to Puerto Rico
Jul 7, 2025 11:29am
UK professional orgs call for actions to improve trial diversity
Jun 17, 2025 3:30pm
AbbVie taps oncology research org for aid running diverse trials
May 28, 2025 11:25am
